Authenticx, a provider of conversational intelligence solutions for healthcare organizations to aggregate and analyze customer interaction/feedback data (like voice, chat, or emails) to find new growth opportunities in the healthcare industry, raised $20 million in Series B funding.
Blue Heron Capital led the investment round with participation from Beringea, Indiana Next Level Fund/50 South Capital Advisors, High Alpha, Mutual Capital Partners, Signal Peak Ventures, Allos Ventures, Elevate Ventures, and M25.
Including the latest funding round, Authenticx has raised close to $30 million in funding to date. The company previously secured $10 million in Seed and Series A funding rounds from investors, including M25, Elevate Ventures, and Innovatemap Ventures.
Customer feedback data
Unsolicited customer feedback is a valuable resource for healthcare and life science organizations. After analyzing 100 million conversations with healthcare customers, Authenticx identified multiple disruptive themes in contact centers, including failure to provide anticipated information via callbacks, callers becoming stuck between two or more healthcare entities and conflicting information offered by different sources. Access to these comprehensive insights from actual customer conversations enables decision-makers to develop effective strategies for addressing customer frustrations.
Commenting on the funding news, Amy Brown, Founder & CEO of Authenticx, said: “By listening at scale, business leaders can feel confident that the strategies they implement in their organization are backed by data generated from the authentic words of their customers.”
Whether identifying areas of frustration for customers or listening for good news, conversational data can be used to revolutionize the patient experience and remind the workforce of their noble purpose.”
“With this funding, we’ll be able to continue driving innovation in conversational intelligence and machine learning to streamline the patient journey and help staff do their best work,” added Amy Brown.
Investors
Blue Heron Capital, a growth equity firm focused on the healthcare and enterprise technology industries, has invested more than $200 million in digital health startups to date. The equity firm’s latest investment portfolio includes – Yes Hearing, ShiftMed, Vida Diagnostics, Stratasan, ChartSpan, Verato, HomeCare.com, Avizia, WiserTogether, and PresenceLearning.
Tom Benedetti, Co-Founder and Managing Partner at Blue Heron Capital, said: “As healthcare organizations focus on building customer-centric solutions, they need a way to understand the truth of what customers truly want.” “We’re excited to partner with Authenticx and their strategic vision as they continue to align business decisions with patient experience.”
According to our funding database, healthcare data analytics companies have raised approximately $20 billion in funding to date.
The latest funding round in the healthcare data analytics space includes:
Temedica, a provider of artificial intelligence-powered real-world healthcare data aggregation and analytics solutions, raised €25 million in Series B funding led by MIG Capital and a Munich-based family office.
Carta Healthcare, a provider of AI-powered clinical data analytics solutions, raised $20 million in Series B funding from investors, including – Paramark Ventures, Frist Cressey Ventures, American College of Cardiology, Asset Management Ventures, CU Healthcare Innovation Fund, Mass General Brigham, Maverick Ventures Investment Fund, and Storm Ventures.
Click here to read more about the latest digital health funding news…
